Literature DB >> 24431654

"Anti-Mullerian Hormone: Marker for Ovarian Response in Controlled Ovarian Stimulation for IVF Patients": A First Pilot Study in the Indian Population.

Neeta Singh1, Ekta Malik2, Ayan Banerjee2, Kunzang Chosdol2, V Sreenivas3, Suneeta Mittal1.   

Abstract

OBJECTIVE: To measure the levels of early follicular phase Anti-Mullerian hormone (AMH) in Indian patients of IVF and to evaluate the AMH as a predictive marker of ovarian response in assisted reproductive technology outcome.
METHODS: Sixty women (age 25-40 years) selected for in vitro fertilization treatment were included in this study. Analysis of day-2 serum samples was done for the AMH, FSH, Inhibin B, and LH by ELISA kit methods. USG was done for the antral follicle count (AFC) and oocytes' retrieval. Hormone parameters were compared and correlated with the oocytes' retrieval count and the AFC. The discriminant analysis was done to compare relevance of different parameters for predicting ovarian response.
RESULTS: The Anti-Mullerian hormone showed a significant correlation with the oocytes' retrieval after ovulation induction for IVF (r = 0.648, p < 0.0001) and no correlation was seen with serum FSH, LH, and Inhibin. Serum AMH levels show 80 % sensitivity and 80 % specificity in predicting poor ovarian response.
CONCLUSIONS: There is a significant correlation between day-2 serum AMH levels and the oocytes' retrieval count in women undergoing ovulation induction for IVF, and the AMH is a good marker as the negative predictive values for the success of ART. There is no correlation found between other hormonal ovarian reserve markers and the oocytes' retrieval count.

Entities:  

Keywords:  AMH/MIS; Anti-Mullerian hormone; Antral follicle count; Assisted reproductive technology (ART); Oocytes retrieval count

Year:  2013        PMID: 24431654      PMCID: PMC3763058          DOI: 10.1007/s13224-012-0318-6

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  14 in total

1.  Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles.

Authors:  T Ebner; M Sommergruber; M Moser; O Shebl; E Schreier-Lechner; G Tews
Journal:  Hum Reprod       Date:  2006-05-05       Impact factor: 6.918

2.  Relevance of anti-Mullerian hormone measurement in a routine IVF program.

Authors:  C Gnoth; A N Schuring; K Friol; J Tigges; P Mallmann; E Godehardt
Journal:  Hum Reprod       Date:  2008-04-02       Impact factor: 6.918

3.  Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve.

Authors:  László F J M M Bancsi; Frank J M Broekmans; Marinus J C Eijkemans; Frank H de Jong; J Dik F Habbema; Egbert R te Velde
Journal:  Fertil Steril       Date:  2002-02       Impact factor: 7.329

4.  Serum müllerian-inhibiting substance levels during normal menstrual cycles.

Authors:  C L Cook; Y Siow; S Taylor; M E Fallat
Journal:  Fertil Steril       Date:  2000-04       Impact factor: 7.329

5.  Anti-mullerian hormone as a marker of ovarian reserve.

Authors:  Kelton P Tremellen; Michele Kolo; Alan Gilmore; Dharmawijaya N Lekamge
Journal:  Aust N Z J Obstet Gynaecol       Date:  2005-02       Impact factor: 2.100

6.  Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.

Authors:  H G Burger; E C Dudley; J L Hopper; N Groome; J R Guthrie; A Green; L Dennerstein
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

7.  Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?

Authors:  S Muttukrishna; H McGarrigle; R Wakim; I Khadum; D M Ranieri; P Serhal
Journal:  BJOG       Date:  2005-10       Impact factor: 6.531

8.  Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?

Authors:  D Nikolaou; S Lavery; C Turner; R Margara; G Trew
Journal:  Hum Reprod       Date:  2002-04       Impact factor: 6.918

9.  Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

Authors:  A La Marca; S Giulini; A Tirelli; E Bertucci; T Marsella; S Xella; A Volpe
Journal:  Hum Reprod       Date:  2006-10-27       Impact factor: 6.918

10.  Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression during postnatal testis development and in the adult testis of the rat.

Authors:  W M Baarends; J W Hoogerbrugge; M Post; J A Visser; D G De Rooij; M Parvinen; A P Themmen; J A Grootegoed
Journal:  Endocrinology       Date:  1995-12       Impact factor: 4.736

View more
  5 in total

1.  Prediction of different ovarian responses using anti-Müllerian hormone following a long agonist treatment protocol for IVF.

Authors:  Z Heidar; M Bakhtiyari; M Mirzamoradi; S Zadehmodarres; F S Sarfjoo; M A Mansournia
Journal:  J Endocrinol Invest       Date:  2015-05-17       Impact factor: 4.256

2.  An in silico model using prognostic genetic factors for ovarian response in controlled ovarian stimulation: A systematic review.

Authors:  B S Eisele; G C Villalba Silva; C Bessow; R Donato; V K Genro; J S Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2021-03-31       Impact factor: 3.357

3.  Anti Mullerian Hormone: Ovarian response indicator in young patients receiving Long GnRH Agonist Protocol for Ovarian Stimulation.

Authors:  Zehra Jamil; Syeda Sadia Fatima; Rehana Rehman; Faiza Alam; Sara Arif
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

Review 4.  Mid-life fertility: Challenges & policy planning.

Authors:  Umesh N Jindal
Journal:  Indian J Med Res       Date:  2018-12       Impact factor: 2.375

5.  The effect of A1298c polymorphism of the MTHFR gene on anti-Müllerian hormone levels: experimental and Web-based analysis.

Authors:  Seyedeh Zahra Shahrokhi; Faranak Kazerouni; Firouzeh Ghaffari; Morteza Hadizadeh; Zahra Zolfaghary
Journal:  J Clin Lab Anal       Date:  2021-08-08       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.